Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lipatov

Showing results (251-260 of 289) with videos related to

Pageof 29
Sort By:
The New England Journal of Medicine|December 14, 2016
Palbociclib and Letrozole in Advanced Breast CancerRichard S Finn, Miguel Martin, Hope S Rugo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 10, 2013
AVEREL: a randomized phase III Trial evaluating bevacizumab in combination with docetaxel and trastuzumab as first-line therapy for HER2-positive locally recurrent/metastatic breast cancerLuca Gianni, Gilles H Romieu, Michail Lichinitser, et al.
Doklady Biological Sciences : Proceedings of the Academy of Sciences of the USSR, Biological Sciences Sections|August 3, 2007
Diversity of highly pathogenic avian influenza H5N1 viruses that caused epizootic in Western Siberia in 2005V A Evseenko, A V Zaykovskaya, V A Ternovoi, et al.
ACS Nano|December 27, 2018
Gate-Controlled Metal-Insulator Transition in TiS<sub>3</sub> Nanowire Field-Effect TransistorsMichael Randle, Alexey Lipatov, Avinash Kumar, et al.
ACS Nano|December 1, 2018
Quasi-1D TiS<sub>3</sub> Nanoribbons: Mechanical Exfoliation and Thickness-Dependent Raman SpectroscopyAlexey Lipatov, Michael J Loes, Haidong Lu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 22, 2024
Overall Survival With Palbociclib Plus Letrozole in Advanced Breast CancerDennis J Slamon, Véronique Diéras, Hope S Rugo, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 19, 2004
H5N1 influenza: a protean pandemic threatY Guan, L L M Poon, C Y Cheung, et al.
Georgian Medical News|June 14, 2026
ELECTRONIC TRAINING PROGRAM «DRAINAGE IN MINE-BLAST INJURIES» FOR STUDYING THE MODULES OF GENERAL SURGERYA Kazantcev, K Lipatov, A Deushev, et al.
Breast Cancer Research and Treatment|January 12, 2019
Palbociclib plus letrozole as first-line therapy in estrogen receptor-positive/human epidermal growth factor receptor 2-negative advanced breast cancer with extended follow-upH S Rugo, R S Finn, V Diéras, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 10, 2016
Quality-of-life and performance status results from the phase III RAINBOW study of ramucirumab plus paclitaxel versus placebo plus paclitaxel in patients with previously treated gastric or gastroesophageal junction adenocarcinomaS-E Al-Batran, E Van Cutsem, S C Oh, et al.
Pageof 29

Showing results (251-260 of 289) with videos related to

Sort By:
Pageof 29
The New England Journal of Medicine|December 14, 2016
Palbociclib and Letrozole in Advanced Breast CancerRichard S Finn, Miguel Martin, Hope S Rugo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 10, 2013
AVEREL: a randomized phase III Trial evaluating bevacizumab in combination with docetaxel and trastuzumab as first-line therapy for HER2-positive locally recurrent/metastatic breast cancerLuca Gianni, Gilles H Romieu, Michail Lichinitser, et al.
Doklady Biological Sciences : Proceedings of the Academy of Sciences of the USSR, Biological Sciences Sections|August 3, 2007
Diversity of highly pathogenic avian influenza H5N1 viruses that caused epizootic in Western Siberia in 2005V A Evseenko, A V Zaykovskaya, V A Ternovoi, et al.
ACS Nano|December 27, 2018
Gate-Controlled Metal-Insulator Transition in TiS<sub>3</sub> Nanowire Field-Effect TransistorsMichael Randle, Alexey Lipatov, Avinash Kumar, et al.
ACS Nano|December 1, 2018
Quasi-1D TiS<sub>3</sub> Nanoribbons: Mechanical Exfoliation and Thickness-Dependent Raman SpectroscopyAlexey Lipatov, Michael J Loes, Haidong Lu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 22, 2024
Overall Survival With Palbociclib Plus Letrozole in Advanced Breast CancerDennis J Slamon, Véronique Diéras, Hope S Rugo, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 19, 2004
H5N1 influenza: a protean pandemic threatY Guan, L L M Poon, C Y Cheung, et al.
Georgian Medical News|June 14, 2026
ELECTRONIC TRAINING PROGRAM «DRAINAGE IN MINE-BLAST INJURIES» FOR STUDYING THE MODULES OF GENERAL SURGERYA Kazantcev, K Lipatov, A Deushev, et al.
Breast Cancer Research and Treatment|January 12, 2019
Palbociclib plus letrozole as first-line therapy in estrogen receptor-positive/human epidermal growth factor receptor 2-negative advanced breast cancer with extended follow-upH S Rugo, R S Finn, V Diéras, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 10, 2016
Quality-of-life and performance status results from the phase III RAINBOW study of ramucirumab plus paclitaxel versus placebo plus paclitaxel in patients with previously treated gastric or gastroesophageal junction adenocarcinomaS-E Al-Batran, E Van Cutsem, S C Oh, et al.
Pageof 29